http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105708800-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate | 2016-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105708800-B |
| titleOfInvention | A kind of Lovastatin silica nodule for targetting breast carcinoma stem cell |
| abstract | The invention discloses a kind of Lovastatin silica nodule for targetting breast carcinoma stem cell and preparation method thereof, the Lovastatin silica nodule contains the component of following percentage by weight：Lovastatin：2% -30%, organo-mineral complexing lipid：20% -70%, phosphatidyl-ethanolamine polyethylene glycol 2000：1% -20%, DSPC：10% -60%.The Lovastatin silica nodule overcomes the problem of Lovastatin Drug bioavailability is low in the prior art. |
| priorityDate | 2016-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.